Cancer

Chemotherapy-induced nausea and vomiting in compliance with the National Comprehensive Cancer Network guideline

Chemotherapy-induced nausea and vomiting (CINV) is a serious adverse effect of cancer therapy. It is observed to different degrees depending on the cytotoxic agent(s) administered. At the American Hospital in Istanbul, the most up-to-date antiemesis guideline by the National Comprehensive Cancer Net…

Lower-GI bleeding should be investigated in anticoagulated patients, researchers say

Lower gastrointestinal bleeding in patients with atrial fibrillation who are being treated with oral anticoagulants is associated with a higher risk of being diagnosed with colorectal cancer, a study published in the European Heart Journal suggests.…

Going against type: the new class of cancer therapies targeting mutations rather than tissues

‘Tumour agnostic’ drugs offer a more effective and tolerable therapy for a wide range of people with cancer, so why has the NHS rejected its first one?…

Statins could be linked to reduced risk of ovarian cancer, researchers find

Women who take statins long-term, including those carrying the BRCA1/2 gene mutation, could be less likely to develop ovarian cancer than those who do not, research published in JAMA has suggested.…

Step counting can help predict outcomes for patients undergoing lung cancer treatment

Measuring patients’ step counts before they receive lung cancer treatment could help predict outcomes, research published in the International Journal of Radiation Oncology, Biology, Physics has suggested.…

Improving oral health: preventative care messages in community pharmacy

Dental caries, periodontal disease and oral cancer are health problems that can be prevented with the help of community pharmacists.…

Trials of HPV vaccine may have overestimated its efficacy, study finds

The efficacy of human papillomavirus vaccines as a preventative for cervical cancer may have been overestimated in trials, a review in the Journal of the Royal Society of Medicine has concluded.…

The most innovative cancer drugs take longest to reach patients, study suggests

The most innovative new cancer drugs are taking longer to pass through clinical trials, licensing and eventual appraisal by the National Institute for Health and Care Excellence, an analysis carried out by the Institute of Cancer Research has suggested.…

It’s time for comprehensive polypharmacy reviews for older people with cancer

The number of older people with cancer is growing and so is their risk of harmful polypharmacy — care for this expanding group of patients must improve.…

Treatment of acute and chronic lymphoid leukaemia

Pharmacists should be able to describe the differences between acute lymphoblastic and chronic lymphocytic leukaemia and the available treatment.…